Peptide SMIM30 promotes HCC development by inducing SRC/YES1 membrane anchoring and MAPK pathway activation

原癌基因酪氨酸蛋白激酶Src MAPK/ERK通路 细胞生物学 癌变 癌症研究 细胞生长 癌症 信号转导 生物 遗传学
作者
Yanan Pang,Zhiyong Liu,Huan Han,Beilei Wang,Wei Li,Chuanbin Mao,Shanrong Liu
出处
期刊:Journal of Hepatology [Elsevier BV]
卷期号:73 (5): 1155-1169 被引量:178
标识
DOI:10.1016/j.jhep.2020.05.028
摘要

•SMIM30 peptide is highly expressed in HCC tissues. •SMIM30 peptide promotes the proliferation and migration of HCC cells both in vitro and in vivo. •SMIM30 is an important adaptor for the membrane anchoring and activation state of SRC/YES1. •MAPK signaling pathway is activated by SRC/YES1-SMIM30 complexes. Background & Aims Growing evidence shows that some non-coding RNAs (ncRNAs) contain small open reading frames (smORFs) that are translated into short peptides. Herein, we aimed to determine where and how these short peptides might promote hepatocellular carcinoma (HCC) development. Methods We performed an RNA-immunoprecipitation followed by high-throughput sequencing (RIP-seq) assay with an antibody against ribosomal protein S6 (RPS6) on 4 cancer cell lines. Focusing on 1 long non-coding RNA (lncRNA), LINC00998, we used qPCR and public databases to evaluate its expression level in patients with HCC. Special vectors were constructed to confirm its coding potential. We also explored the function and mechanism of LINC00998-encoded peptide in tumor growth and metastasis. Results We discovered that many lncRNAs bind to RPS6 in cancer cells. One of these lncRNAs, LINC00998, encoded a small endogenous peptide, termed SMIM30. SMIM30, rather than the RNA itself, promoted HCC tumorigenesis by modulating cell proliferation and migration, and its level was correlated with poor survival in patients with HCC. Furthermore, SMIM30 was transcribed by c-Myc and then drove the membrane anchoring of the non-receptor tyrosine kinases SRC/YES1. Moreover, the downstream MAPK signaling pathway was activated by SRC/YES1. Conclusions Our results not only unravel a new mechanism of HCC tumorigenesis promoted by ncRNA-encoded peptides, but also suggest that these peptides can serve as a new target for HCC cancer therapy and a new biomarker for HCC diagnosis and prognosis. Lay summary Very little is known about how peptides activate signaling pathways that play a crucial role in diseases such as cancer. Specifically, we reported on a conserved peptide encoded by LINC00998, SMIM30. This peptide promoted the tumorigenesis of hepatocellular carcinoma (HCC) by modulating cell proliferation and migration. Of note, it bound the non-receptor tyrosine kinases, SRC/YES1, to drive their membrane anchoring and phosphorylation, activating the downstream MAPK signaling pathway. Our work not only unravels a new mechanism of HCC tumorigenesis promoted by peptides, but also demonstrates how the peptide works to activate a signaling pathway. Growing evidence shows that some non-coding RNAs (ncRNAs) contain small open reading frames (smORFs) that are translated into short peptides. Herein, we aimed to determine where and how these short peptides might promote hepatocellular carcinoma (HCC) development. We performed an RNA-immunoprecipitation followed by high-throughput sequencing (RIP-seq) assay with an antibody against ribosomal protein S6 (RPS6) on 4 cancer cell lines. Focusing on 1 long non-coding RNA (lncRNA), LINC00998, we used qPCR and public databases to evaluate its expression level in patients with HCC. Special vectors were constructed to confirm its coding potential. We also explored the function and mechanism of LINC00998-encoded peptide in tumor growth and metastasis. We discovered that many lncRNAs bind to RPS6 in cancer cells. One of these lncRNAs, LINC00998, encoded a small endogenous peptide, termed SMIM30. SMIM30, rather than the RNA itself, promoted HCC tumorigenesis by modulating cell proliferation and migration, and its level was correlated with poor survival in patients with HCC. Furthermore, SMIM30 was transcribed by c-Myc and then drove the membrane anchoring of the non-receptor tyrosine kinases SRC/YES1. Moreover, the downstream MAPK signaling pathway was activated by SRC/YES1. Our results not only unravel a new mechanism of HCC tumorigenesis promoted by ncRNA-encoded peptides, but also suggest that these peptides can serve as a new target for HCC cancer therapy and a new biomarker for HCC diagnosis and prognosis.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
2秒前
Tiffany完成签到,获得积分10
3秒前
武雨寒发布了新的文献求助10
3秒前
姜睿思发布了新的文献求助10
3秒前
鳗鱼思松发布了新的文献求助10
5秒前
liuzhixiao发布了新的文献求助10
5秒前
zxb发布了新的文献求助10
5秒前
6秒前
7秒前
湿地小怪兽完成签到,获得积分10
7秒前
qqqqqqqqqqq完成签到,获得积分10
8秒前
9秒前
我是老大应助七七采纳,获得10
9秒前
11秒前
liuzhanyu完成签到,获得积分10
12秒前
zzx发布了新的文献求助10
13秒前
阡陌完成签到 ,获得积分10
13秒前
yeziyang发布了新的文献求助10
14秒前
wu发布了新的文献求助10
14秒前
角落的蘑菇完成签到,获得积分10
14秒前
dt完成签到,获得积分10
14秒前
16秒前
jerryzhu发布了新的文献求助10
16秒前
过时的不评完成签到,获得积分10
16秒前
17秒前
丘比特应助阿关采纳,获得10
17秒前
自信鬼神完成签到,获得积分10
19秒前
20秒前
wu完成签到,获得积分20
21秒前
lumangxiaozi完成签到,获得积分10
22秒前
大帅哥发布了新的文献求助10
22秒前
22秒前
23秒前
24秒前
24秒前
香蕉觅云应助科研通管家采纳,获得10
25秒前
赘婿应助科研通管家采纳,获得10
25秒前
yar应助科研通管家采纳,获得10
25秒前
高分求助中
【重要!!请各位用户详细阅读此贴】科研通的精品贴汇总(请勿应助) 10000
Semantics for Latin: An Introduction 1099
醤油醸造の最新の技術と研究 1000
Plutonium Handbook 1000
Three plays : drama 1000
Robot-supported joining of reinforcement textiles with one-sided sewing heads 640
北师大毕业论文 基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 530
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4110621
求助须知:如何正确求助?哪些是违规求助? 3649026
关于积分的说明 11557786
捐赠科研通 3354255
什么是DOI,文献DOI怎么找? 1842816
邀请新用户注册赠送积分活动 909036
科研通“疑难数据库(出版商)”最低求助积分说明 825914